Read + Share
Amedeo Smart
Independent Medical Education
Kalogera E, Nevala WK, Finnes HD, Suman VJ, et al. A Phase I trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies. Clin Cancer Res 2024 Mar 26. doi: 10.1158/1078-0432.CCR-23-3196.PMID: 38530846
Email
LinkedIn
Facebook
Twitter
Privacy Policy